{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:34:35Z","timestamp":1795026875613,"version":"4.10.2"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048176"],"award-info":[{"award-number":["R01DA048176"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jsat.2021.108399","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T21:41:05Z","timestamp":1618954865000},"page":"108399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities"],"prefix":"10.1016","volume":"127","author":[{"given":"Jeanne C.","family":"Marsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortensia","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenie","family":"Khachikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108399_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13311-019-00814-4","article-title":"Availability of medications for the treatment of alcohol and opioid use disorder in the U.S.A","volume":"17","author":"Abraham","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"10077","key":"10.1016\/j.jsat.2021.108399_bb0010","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: Evidence and interventions","volume":"389","author":"Bailey","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.jsat.2021.108399_bb0015","article-title":"Opioid use disorder in women and the implications for treatment","volume":"xx:0","author":"Barbosa-Leiker","year":"2020","journal-title":"Psychiatric Research in Clinical Practice"},{"issue":"4","key":"10.1016\/j.jsat.2021.108399_bb0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3109\/00952990.2011.591016","article-title":"Improving health and social outcomes with targeted services in comprehensive substance abuse treatment","volume":"37","author":"Cao","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2021.108399_bb0025","first-page":"1","article-title":"Drug overdose deaths among women aged 30-64 years \u2013 United States, 1999-2017","volume":"68","author":"Centers for Disease Control MMWR","year":"2019","journal-title":"January 11, 2019"},{"issue":"26","key":"10.1016\/j.jsat.2021.108399_bb0030","first-page":"537","article-title":"Vital signs: Overdoses of prescription opioid pain relievers and other drugs among women \u2013 United States 1999-2010","volume":"62","author":"Centers for Disese Control MMWR","year":"2013","journal-title":"July 5, 3013"},{"key":"10.1016\/j.jsat.2021.108399_bb0035","article-title":"Final report: Opioid Use, Misuse, and Overdose in Women","author":"DHHS Office on Women\u2019s Health (HHS OWH)","year":"2017","journal-title":"Misuse, and Overdose in Women"},{"issue":"1","key":"10.1016\/j.jsat.2021.108399_bb0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1940-0640-7-10","article-title":"Just call it \u201ctreatment\u201d","volume":"7","author":"Friedmann","year":"2012","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.jsat.2021.108399_bb0045","doi-asserted-by":"crossref","first-page":"e203711","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the U.S","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.jsat.2021.108399_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.05.012","article-title":"Substance abuse treatment entry, retention, and outcome in women: A review of the literature","volume":"86","author":"Greenfield","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108399_bb0055","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/0193841X0002400402","article-title":"Program variation in treatment outcomes among women in residential drug treatment","volume":"24","author":"Grella","year":"2000","journal-title":"Evaluation Review"},{"issue":"6\u20137","key":"10.1016\/j.jsat.2021.108399_bb0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.addbeh.2009.01.002","article-title":"Gender and comorbidity among indivduals with opioid use disorders in the NESARC study","volume":"34","author":"Grella","year":"2009","journal-title":"Addictive Behaviors"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2021.108399_bb0065","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.drugalcdep.2011.05.020","article-title":"Cultural competence in outpatient substance abuse treatment: Measurement and relationship to access and retention","volume":"119","author":"Guerrero","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2021.108399_bb0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.drugalcdep.2013.04.005","article-title":"Enhancing access and retention in substance abuse treatment: The role of Medicaid payment acceptance and cultural competence","volume":"132","author":"Guerrero","year":"2013","journal-title":"Drug & Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2021.108399_bb8000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1475-6773.12031","article-title":"Disparities in completion of substance abuse treatment between and within racial and ethnic groups","volume":"48","author":"Guerrero","year":"2013","journal-title":"Health Service Research"},{"issue":"1","key":"10.1016\/j.jsat.2021.108399_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10488-014-0617-6","article-title":"Program capacity to eliminate outcome disparities in addiction health services.","volume":"43","author":"Guerrero","year":"2014","journal-title":"Administration and Policy in Mental Health and Mental Health Services Research"},{"key":"10.1016\/j.jsat.2021.108399_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13011-015-0036-z","article-title":"Paths to improving engagement among racial and ethnic minorities in addiction health services","volume":"10","author":"Guerrero","year":"2015","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.jsat.2021.108399_bb0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jsat.2019.07.009","article-title":"Drivers of continued implementation of cultural competence in substance use disorder treatment","volume":"105","author":"Guerrero","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108399_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.evalprogplan.2013.05.002","article-title":"Organizational structure, leadership and readiness for change and the implementation of organizational cultural competence in addiction health services","volume":"40","author":"Guerrero","year":"2013","journal-title":"Evaluation and Program Planning"},{"issue":"5","key":"10.1016\/j.jsat.2021.108399_bb0095","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jsat.2013.12.008","article-title":"Gender disparities in utilization and outcome of comprehensive substance abuse treatment among racial\/ethnic groups","volume":"46","author":"Guerrero","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2021.108399_bb0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2012.12.008","article-title":"Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes","volume":"131","author":"Haddad","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108399_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to brprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.jsat.2021.108399_bb0110","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2105\/AJPH.2005.077628","article-title":"Advancing health disparities research with the health care system: A conceptual framework","volume":"96","author":"Kilbourne","year":"2006","journal-title":"The American Journal of Public Health"},{"key":"10.1016\/j.jsat.2021.108399_bb0115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.drugalcdep.2017.06.009","article-title":"Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample","volume":"178","author":"Krawczyk","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108399_bb0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.drugalcdep.2019.02.007","article-title":"A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions","volume":"197","author":"Ling","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108399_bb0125","series-title":"NAM perspectives. Discussion paper, Washington, D.C.","author":"Madras","year":"2020"},{"issue":"Supplement_2","key":"10.1016\/j.jsat.2021.108399_bb0130","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/infdis\/jiz214","article-title":"The impact of unconscious bias in healthcare: How to recognize and mitigate it","volume":"220","author":"Marcelin","year":"2019","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"10.1016\/j.jsat.2021.108399_bb0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jsat.2004.08.004","article-title":"Gender differences in the impact of comprehensive services in substance abuse treatment","volume":"27","author":"Marsh","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2021.108399_bb9000","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/swr\/33.3.183","article-title":"Closing the need-service gap: Gender Differences in matching services to client needs in comprehensive substance abuse treatment","volume":"33","author":"Marsh","year":"2009","journal-title":"Social Work Research"},{"key":"10.1016\/j.jsat.2021.108399_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jsat.2018.01.001","article-title":"Gender differnces in trends for heroin use and nonmedical prescription opioid use, 2007-2014","volume":"87","author":"Marsh","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.jsat.2021.108399_bb0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/15332640.2018.1548323","article-title":"Anti-racism and substance use treatment: Addiction does not discriminate, but do we?","volume":"19","author":"Matsuzaka","year":"2020","journal-title":"Journal of Ethnicity in Substance Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2021.108399_bb0155","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"16","author":"Mattick","year":"2008","journal-title":"Cochrane Database Systematic Review"},{"issue":"4","key":"10.1016\/j.jsat.2021.108399_bb0160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0899-3289(96)90002-4","article-title":"Variation in access to outpatient substance abuse treatment: Organizational factors and conceptual issues","volume":"8","author":"McCaughrin","year":"1996","journal-title":"Journal of Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108399_bb0165","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and Medicine [NASEM]","year":"2019"},{"key":"10.1016\/j.jsat.2021.108399_bb0170","unstructured":"NIDA. (2019, July 16). Access to addiction services differs by race and gender. Retrieved from https:\/\/www.drugabuse.gov\/about-nida\/noras-blog\/2019\/07\/access-to-addiction-services-differs-by-race-gender on 2020, June 1."},{"key":"10.1016\/j.jsat.2021.108399_bb0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/add.12376","article-title":"Commentary on Hser et al. (2014): To retain or not to retain \u2013 Open questions in opioid maintenance therapy","volume":"109","author":"Soyka","year":"2013","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.jsat.2021.108399_bb0180","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.2105\/AJPH.2015.302821","article-title":"Women-centered drug treatment services and need in the United States, 2002-2009","volume":"105","author":"Terplan","year":"2015","journal-title":"American Journal of Public Health"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221001252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:55:30Z","timestamp":1760039730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221001252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":37,"alternative-id":["S0740547221001252"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108399","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108399"}}